Stage IIIC Non-Small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch Stage IIIC Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer (NCT06525246) | Ono Pharmaceutical Co., Ltd. | 2021-08-06 |
Track Stage IIIC Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.